Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Gregory Forlenza

Concepts (235)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Insulin Infusion Systems
92
2026
477
17.240
Why?
Diabetes Mellitus, Type 1
115
2026
3906
12.340
Why?
Insulin
94
2026
2507
9.390
Why?
Blood Glucose Self-Monitoring
79
2026
699
9.100
Why?
Hypoglycemic Agents
89
2026
1391
9.040
Why?
Pancreas, Artificial
31
2025
97
8.810
Why?
Blood Glucose
104
2026
2333
8.550
Why?
Hypoglycemia
35
2026
477
5.690
Why?
Hyperglycemia
15
2023
376
3.110
Why?
Hematopoietic Stem Cell Transplantation
5
2022
677
1.980
Why?
Diabetes Mellitus
10
2025
1098
1.690
Why?
Islets of Langerhans Transplantation
5
2024
67
1.630
Why?
Monitoring, Ambulatory
5
2018
89
1.620
Why?
Child
66
2026
22712
1.470
Why?
Adolescent
67
2026
22507
1.430
Why?
Pancreatectomy
5
2024
285
1.370
Why?
Algorithms
18
2025
1846
1.370
Why?
Humans
147
2026
145305
1.320
Why?
Insulin-Secreting Cells
3
2023
388
1.260
Why?
Pancreatitis, Chronic
4
2024
63
1.160
Why?
Biomedical Technology
2
2019
49
1.100
Why?
Young Adult
39
2026
14163
1.090
Why?
Verapamil
2
2023
37
0.990
Why?
Patient Education as Topic
3
2021
782
0.960
Why?
Diabetes Mellitus, Type 2
8
2025
2592
0.950
Why?
Adult
56
2026
40627
0.910
Why?
Male
64
2026
72628
0.830
Why?
Technology
5
2023
96
0.780
Why?
Telemedicine
3
2022
957
0.770
Why?
Female
62
2026
78605
0.760
Why?
Calcium Channel Blockers
1
2023
165
0.740
Why?
Caregivers
3
2025
1056
0.700
Why?
Child, Preschool
19
2025
11863
0.680
Why?
Lymphoma
1
2023
233
0.670
Why?
Self-Management
2
2026
201
0.660
Why?
Glucose
9
2024
1049
0.650
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2023
294
0.600
Why?
Patient Dropouts
1
2020
65
0.590
Why?
Treatment Outcome
19
2026
11731
0.590
Why?
Patient Satisfaction
3
2024
706
0.570
Why?
Personal Satisfaction
1
2020
222
0.550
Why?
Diabetic Ketoacidosis
5
2024
210
0.540
Why?
Eczema
1
2018
66
0.530
Why?
Transplantation Conditioning
1
2019
186
0.530
Why?
Betacoronavirus
1
2020
285
0.510
Why?
Diabetic Retinopathy
2
2024
208
0.480
Why?
Diffusion of Innovation
1
2017
98
0.480
Why?
Machine Learning
2
2025
589
0.450
Why?
Endocrine Glands
1
2015
14
0.450
Why?
Insulin, Regular, Human
7
2023
47
0.450
Why?
Quality of Life
4
2024
3197
0.440
Why?
Transplantation, Autologous
4
2024
292
0.440
Why?
Retrospective Studies
13
2025
17149
0.440
Why?
Endocrine System Diseases
1
2015
35
0.440
Why?
Insulin Lispro
3
2024
42
0.440
Why?
Pneumonia, Viral
1
2020
386
0.440
Why?
Aged
21
2026
26001
0.430
Why?
Coronavirus Infections
1
2020
380
0.430
Why?
C-Peptide
3
2025
189
0.430
Why?
Exercise
9
2025
2206
0.420
Why?
Artificial Intelligence
1
2019
378
0.420
Why?
Fanconi Anemia
1
2013
11
0.410
Why?
United States
16
2026
16051
0.410
Why?
Dwarfism
1
2013
15
0.410
Why?
Cross-Over Studies
7
2026
610
0.400
Why?
Growth Hormone
1
2013
92
0.400
Why?
Awareness
2
2026
110
0.400
Why?
Skin
1
2018
758
0.390
Why?
Middle Aged
24
2026
36021
0.380
Why?
Blindness
1
2012
52
0.370
Why?
Suicide
1
2020
726
0.360
Why?
Sequence Analysis, DNA
1
2015
824
0.360
Why?
High-Throughput Nucleotide Sequencing
1
2015
550
0.350
Why?
Pandemics
1
2020
1698
0.340
Why?
Angiogenesis Inhibitors
1
2012
237
0.330
Why?
Biosensing Techniques
2
2025
139
0.330
Why?
Calibration
3
2020
151
0.330
Why?
Lingual Frenum
1
2010
2
0.320
Why?
Tongue Diseases
1
2010
9
0.320
Why?
Failure to Thrive
1
2010
28
0.320
Why?
Cardiovascular Diseases
1
2022
2182
0.320
Why?
Epidemics
1
2011
98
0.310
Why?
Randomized Controlled Trials as Topic
1
2016
1747
0.310
Why?
Vascular Endothelial Growth Factor A
1
2012
557
0.310
Why?
Medicaid
3
2022
466
0.300
Why?
Medicare
3
2025
890
0.300
Why?
Models, Biological
1
2016
1823
0.290
Why?
Double-Blind Method
4
2023
2033
0.280
Why?
Infant
6
2023
10101
0.280
Why?
Skiing
2
2019
49
0.260
Why?
Follow-Up Studies
5
2021
5431
0.260
Why?
Adolescent Nutritional Physiological Phenomena
2
2017
29
0.260
Why?
Inventions
2
2018
19
0.260
Why?
Prospective Studies
7
2025
8011
0.250
Why?
Insurance Coverage
2
2025
243
0.240
Why?
Endocrinology
2
2018
77
0.230
Why?
Feasibility Studies
6
2026
1103
0.230
Why?
Meals
4
2024
130
0.230
Why?
Insulin Aspart
2
2022
30
0.230
Why?
Outpatients
2
2021
443
0.230
Why?
Injections, Subcutaneous
3
2020
164
0.220
Why?
Overweight
2
2023
610
0.220
Why?
Risk Factors
5
2020
10816
0.220
Why?
Postoperative Complications
2
2015
2938
0.210
Why?
Body Height
2
2017
202
0.210
Why?
Mutation
1
2015
4104
0.200
Why?
Insulins
1
2023
38
0.180
Why?
Equipment Failure
3
2018
115
0.180
Why?
Eligibility Determination
1
2022
72
0.180
Why?
Patient Safety
1
2025
349
0.180
Why?
Pediatrics
2
2020
1118
0.170
Why?
Automobile Driving
1
2023
157
0.160
Why?
Infusion Pumps, Implantable
1
2020
26
0.160
Why?
Computer Systems
1
2020
56
0.150
Why?
Smartphone
2
2019
102
0.150
Why?
Europe
3
2025
416
0.150
Why?
Sports
2
2019
212
0.150
Why?
Product Surveillance, Postmarketing
1
2019
73
0.150
Why?
Fatal Outcome
1
2020
307
0.150
Why?
Reproducibility of Results
4
2024
3419
0.140
Why?
Prevalence
3
2023
2838
0.140
Why?
Clinical Alarms
1
2017
10
0.130
Why?
Software
2
2021
692
0.130
Why?
Night Terrors
1
2017
1
0.130
Why?
Insulinoma
1
2017
28
0.130
Why?
Device Approval
1
2017
19
0.130
Why?
Diet, Diabetic
1
2017
33
0.130
Why?
Voluntary Health Agencies
1
2016
6
0.130
Why?
Survival Analysis
1
2020
1386
0.130
Why?
Adrenal Hyperplasia, Congenital
1
2017
39
0.120
Why?
Program Evaluation
1
2021
949
0.120
Why?
Pancreaticoduodenectomy
1
2017
135
0.120
Why?
Obesity
3
2023
3085
0.120
Why?
United States Food and Drug Administration
1
2017
205
0.120
Why?
Statistics as Topic
1
2016
284
0.120
Why?
Abdominal Pain
1
2017
146
0.120
Why?
Hypophosphatasia
1
2015
5
0.110
Why?
Age Factors
3
2018
3339
0.110
Why?
Drug Overdose
1
2020
370
0.110
Why?
Automation
2
2025
102
0.110
Why?
Drug Delivery Systems
1
2018
382
0.110
Why?
Alkaline Phosphatase
1
2015
145
0.110
Why?
History, 21st Century
2
2025
220
0.110
Why?
Autografts
1
2014
55
0.100
Why?
Pilot Projects
2
2020
1894
0.100
Why?
Health Services Accessibility
1
2022
1104
0.100
Why?
History, 20th Century
2
2025
327
0.100
Why?
Choristoma
1
2013
21
0.100
Why?
Glucose Clamp Technique
1
2014
199
0.100
Why?
Primary Ovarian Insufficiency
1
2013
40
0.100
Why?
Infusions, Intravenous
1
2014
423
0.100
Why?
Postoperative Period
1
2014
354
0.100
Why?
Clinical Decision-Making
1
2016
360
0.100
Why?
Pituitary Gland
1
2013
148
0.100
Why?
Graft Survival
1
2015
528
0.100
Why?
Allografts
1
2013
150
0.100
Why?
Bionics
2
2022
14
0.090
Why?
Patient Compliance
1
2017
589
0.090
Why?
Clinical Protocols
1
2014
282
0.090
Why?
Surveys and Questionnaires
2
2024
6079
0.090
Why?
Graft Rejection
1
2015
542
0.090
Why?
Genetic Testing
1
2015
482
0.090
Why?
Quality Improvement
1
2021
1296
0.090
Why?
Adolescent Behavior
1
2017
501
0.090
Why?
Pituitary Neoplasms
1
2013
190
0.090
Why?
Adipose Tissue
1
2016
653
0.090
Why?
Body Mass Index
2
2017
2439
0.090
Why?
Prognosis
2
2020
4310
0.080
Why?
Age of Onset
1
2012
551
0.080
Why?
Longitudinal Studies
3
2024
2959
0.080
Why?
Biomedical Research
1
2016
713
0.080
Why?
Critical Illness
1
2016
893
0.070
Why?
Activities of Daily Living
3
2017
441
0.070
Why?
Global Health
1
2012
403
0.070
Why?
Pancreatic Neoplasms
1
2017
928
0.070
Why?
Consensus
2
2022
476
0.070
Why?
Biomarkers
1
2020
4284
0.070
Why?
Electronic Health Records
1
2016
1177
0.070
Why?
Guideline Adherence
1
2012
589
0.070
Why?
Case-Control Studies
1
2015
3613
0.070
Why?
Equipment Design
2
2019
530
0.070
Why?
Societies, Medical
2
2024
893
0.060
Why?
Hospitalization
3
2024
2443
0.060
Why?
Infant, Newborn
1
2019
6456
0.060
Why?
Cold Temperature
2
2019
210
0.060
Why?
Weight Gain
1
2010
564
0.060
Why?
Breast Feeding
1
2010
448
0.060
Why?
Disposable Equipment
1
2026
24
0.060
Why?
Incidence
1
2012
2892
0.060
Why?
Time Factors
3
2025
7186
0.060
Why?
Seasons
2
2019
557
0.060
Why?
Practice Guidelines as Topic
1
2012
1568
0.050
Why?
Risk
2
2017
912
0.050
Why?
Child Abuse
1
2010
555
0.050
Why?
Combined Modality Therapy
2
2017
1268
0.050
Why?
Mass Screening
1
2012
1357
0.050
Why?
Diet
1
2011
1285
0.050
Why?
Quality-Adjusted Life Years
1
2023
122
0.050
Why?
Bayes Theorem
1
2025
433
0.050
Why?
Insulin Resistance
1
2011
1243
0.050
Why?
Standard of Care
1
2023
80
0.050
Why?
Pregnancy
2
2025
7208
0.040
Why?
Aged, 80 and over
2
2026
8295
0.040
Why?
Reference Standards
1
2021
178
0.040
Why?
Cohort Studies
2
2025
5982
0.040
Why?
Intention to Treat Analysis
1
2020
80
0.040
Why?
Cost-Benefit Analysis
1
2023
639
0.040
Why?
Social Conditions
1
2019
13
0.040
Why?
Pancreas
1
2022
342
0.040
Why?
Inpatients
1
2024
551
0.040
Why?
Disease Management
1
2023
647
0.040
Why?
Equipment and Supplies
1
2018
35
0.040
Why?
Health Personnel
1
2025
748
0.040
Why?
International Cooperation
1
2018
198
0.030
Why?
Postprandial Period
1
2018
118
0.030
Why?
Virginia
1
2017
55
0.030
Why?
Snacks
1
2017
23
0.030
Why?
Colorado
2
2017
4579
0.030
Why?
Mobile Applications
1
2020
196
0.030
Why?
Ohio
1
2017
145
0.030
Why?
Reference Values
1
2018
798
0.030
Why?
Child Nutritional Physiological Phenomena
1
2017
106
0.030
Why?
Minnesota
1
2017
169
0.030
Why?
Accelerometry
1
2017
119
0.030
Why?
Single-Blind Method
1
2017
319
0.030
Why?
Hypertrophy
1
2016
127
0.030
Why?
Food Preferences
1
2017
126
0.030
Why?
Materials Testing
1
2017
355
0.030
Why?
Healthcare Disparities
1
2022
736
0.030
Why?
Child Behavior
1
2017
236
0.030
Why?
Pain Measurement
1
2017
555
0.030
Why?
Feeding Behavior
1
2018
692
0.020
Why?
Practice Patterns, Physicians'
1
2018
1358
0.020
Why?
Severity of Illness Index
1
2017
2926
0.020
Why?
Magnetic Resonance Imaging
1
2017
3888
0.010
Why?
Forlenza's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)